logo

For the Inventor, By the Inventor

Riehen, Switzerland

Roland M Wenger

This inventor holds 17 USPTO granted patents. Top assignees: Novartis Ag, Sandoz Gmbh, Debiopharm S.a.. Active years: 1981-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland M Wenger. Retrieved from https://idiyas.com/inventor/roland-m-wenger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 76.5

Average Co-Inventor Count = 2.3

ph-index = 11

Forward Citations = 501(Granted Patents)


Location History:

  • Richen, CH (2004)
  • Riehen, CH (1981 - 2013)

Company Filing History:

goldMedal6 out of 3,975 
 
Novartis Ag
 patents
silverMedal6 out of 1,603 
 
Sandoz Gmbh
 patents
bronzeMedal4 out of 28 
 
Debiopharm S.a.
 patents
4. 1 out of 15 
 
Debio Recherche Pharmaceutique S.a.
 patents

Years Active: 1981-2013

Loading Chart...
17 patents (USPTO):Explore Patents
1. 8501683 - Cycloundecadepsipeptide compounds and use of said compounds as a medicament (2013-08-06),
2. RE40987 - Cyclosporin with improved activity profile (2009-11-16),
3. 6995139 - Cyclic undecapeptide pro-drugs and uses thereof (2006-02-07),
4. 6927208 - Cyclosporin with improved activity profile (2005-08-09),
5. 6790935 - Cyclosporin derivatives and method for the production of said derivatives (2004-09-14),
6. 6486209 - Use for 1,3-propanediol derivatives (2002-11-26),
7. 6274629 - Use for 1,3-propanediol derivatives (2001-08-14),
8. 6255100 - Cyclosporin fermentation process (2001-07-03),
9. 6187547 - Assay kit (2001-02-13),
10. 5981479 - Cyclosporins (1999-11-09),
11. 5767069 - Cyclosporins (1998-06-16),
12. 5169773 - Monoclonal antibodies to cyclosporins (1992-12-08),
13. 4764503 - Novel cyclosporins (1988-08-16),
14. 4639434 - Novel cyclosporins (1987-01-27),
15. 4554351 - Method for the total synthesis of cyclosporins, novel cyclosporins and (1985-11-19),

Title: Roland M Wenger: Innovator in Medicinal Chemistry

Introduction

Roland M Wenger is a distinguished inventor based in Riehen, Switzerland, known for his significant contributions to medicinal chemistry. With a remarkable portfolio of 17 patents, Wenger has made strides in developing innovative compounds with therapeutic applications.

Latest Patents

Among his latest patents, Wenger has developed cycloundecadepsipeptide compounds, which are particularly noteworthy for their potential use as antiviral agents. These compounds are aimed at preventing or treating Hepatitis C infections and related disorders. Another significant invention is a novel cyclosporin with an improved activity profile, which includes its pharmaceutical use and a composition containing it.

Career Highlights

Wenger has had a fruitful career, working with prominent companies such as Novartis AG and Sandoz GmbH. His work in these organizations has allowed him to contribute to the advancement of pharmaceutical sciences and the development of new therapeutic agents.

Collaborations

Throughout his career, Wenger has collaborated with notable colleagues, including Manfred Mutter and Hans Kobel. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Roland M Wenger's contributions to medicinal chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to impact the development of new treatments for viral infections and other medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…